91 related articles for article (PubMed ID: 23280517)
1. Effects of glucocorticoid receptor antagonist, RU486, on the proliferative and differentiation capabilities of bone marrow mesenchymal stromal cells in ovariectomized rats.
Wei N; Yu Y; Schmidt T; Stanford C; Hong L
J Orthop Res; 2013 May; 31(5):760-7. PubMed ID: 23280517
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid receptor antagonist and siRNA prevent senescence of human bone marrow mesenchymal stromal cells in vitro.
Wei N; Yu Y; Joshi V; Schmidt T; Qian F; Salem AK; Stanford C; Hong L
Cell Tissue Res; 2013 Nov; 354(2):461-70. PubMed ID: 23963647
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of RU486 on proliferation and differentiation capabilities of human bone marrow mesenchymal stromal cells.
Yu Y; Wei N; Stanford C; Schmidt T; Hong L
Steroids; 2012 Jan; 77(1-2):132-7. PubMed ID: 22093480
[TBL] [Abstract][Full Text] [Related]
4. Role of mechanical strain and estrogen in modulating osteogenic differentiation of mesenchymal stem cells (MSCs) from normal and ovariectomized rats.
Li L; Yao XL; He XL; Liu XJ; Wu WC; Kuang W; Tang M
Cell Mol Biol (Noisy-le-grand); 2013 Nov; Suppl 59():OL1889-93. PubMed ID: 24209734
[TBL] [Abstract][Full Text] [Related]
5. Osteogenic differentiation of bone marrow mesenchymal stem cells of ovariectomized and non-ovariectomized female rats with thyroid dysfunction.
Boeloni JN; de M Ocarino N; Silva JF; Corrêa CR; Bertollo CM; Hell RC; de M Pereira M; Goes AM; Serakides R
Pathol Res Pract; 2013 Jan; 209(1):44-51. PubMed ID: 23164717
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of the biological characteristics of mesenchymal stem cells from bone marrow and peripheral blood of rats.
Fu WL; Zhang JY; Fu X; Duan XN; Leung KK; Jia ZQ; Wang WP; Zhou CY; Yu JK
Tissue Eng Part A; 2012 Sep; 18(17-18):1793-803. PubMed ID: 22721583
[TBL] [Abstract][Full Text] [Related]
7. HIV protease inhibitors induce senescence and alter osteoblastic potential of human bone marrow mesenchymal stem cells: beneficial effect of pravastatin.
Hernandez-Vallejo SJ; Beaupere C; Larghero J; Capeau J; Lagathu C
Aging Cell; 2013 Dec; 12(6):955-65. PubMed ID: 23795945
[TBL] [Abstract][Full Text] [Related]
8. Brief treatment with the glucocorticoid receptor antagonist mifepristone normalises the corticosterone-induced reduction of adult hippocampal neurogenesis.
Mayer JL; Klumpers L; Maslam S; de Kloet ER; Joëls M; Lucassen PJ
J Neuroendocrinol; 2006 Aug; 18(8):629-31. PubMed ID: 16867184
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
Gallo D; Zannoni GF; Apollonio P; Martinelli E; Ferlini C; Passetti G; Riva A; Morazzoni P; Bombardelli E; Scambia G
Menopause; 2005; 12(5):589-600. PubMed ID: 16145313
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of glucocorticoid-induced changes of Na(+), K(+)-ATPase in rat lens by a glucocorticoid receptor antagonist RU486.
Xie GL; Yan H; Lu ZF
Exp Eye Res; 2010 Oct; 91(4):544-9. PubMed ID: 20637751
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of the new glucocorticoid receptor antagonist ORG 34517 and RU486 (mifepristone) on glucocorticoid receptor nuclear translocation in the AtT20 cell line.
Peeters BW; Ruigt GS; Craighead M; Kitchener P
Ann N Y Acad Sci; 2008 Dec; 1148():536-41. PubMed ID: 19120154
[TBL] [Abstract][Full Text] [Related]
12. Modulation of intestinal estrogen receptor by ovariectomy, estrogen and growth hormone.
Chen C; Kalu DN
J Pharmacol Exp Ther; 1998 Jul; 286(1):328-33. PubMed ID: 9655876
[TBL] [Abstract][Full Text] [Related]
13. [Effect of estrogen deficiency on the proliferation and osteogenic differentiation potential of mandibular bone marrow stromal cells].
Wang Y; Song W; Jing S; Yu J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Oct; 49(10):619-24. PubMed ID: 25567716
[TBL] [Abstract][Full Text] [Related]
14. PDGF receptor beta is a potent regulator of mesenchymal stromal cell function.
Tokunaga A; Oya T; Ishii Y; Motomura H; Nakamura C; Ishizawa S; Fujimori T; Nabeshima Y; Umezawa A; Kanamori M; Kimura T; Sasahara M
J Bone Miner Res; 2008 Sep; 23(9):1519-28. PubMed ID: 18410236
[TBL] [Abstract][Full Text] [Related]
15. The effects of hyaluronan on bone resorption and bone mineral density in a rat model of estrogen deficiency-induced osteopenia.
Stancíková M; Svík K; Istok R; Rovenský J; Velebný V
Int J Tissue React; 2004; 26(1-2):9-16. PubMed ID: 15573687
[TBL] [Abstract][Full Text] [Related]
16. Decreased proliferation ability and differentiation potential of mesenchymal stem cells of osteoporosis rat.
Wang Q; Zhao B; Li C; Rong JS; Tao SQ; Tao TZ
Asian Pac J Trop Med; 2014 May; 7(5):358-63. PubMed ID: 25063060
[TBL] [Abstract][Full Text] [Related]
17. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
Shen V; Birchman R; Wu DD; Lindsay R
J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
[TBL] [Abstract][Full Text] [Related]
18. Estrogen supplementation modulates effects of the endocrine disrupting pollutant PCB126 in rat bone and uterus: diverging effects in ovariectomized and intact animals.
Lind PM; Eriksen EF; Lind L; Orberg J; Sahlin L
Toxicology; 2004 Jul; 199(2-3):129-36. PubMed ID: 15147787
[TBL] [Abstract][Full Text] [Related]
19. Evidences for antiosteoporotic and selective estrogen receptor modulator activity of silymarin compared with ethinylestradiol in ovariectomized rats.
El-Shitany NA; Hegazy S; El-Desoky K
Phytomedicine; 2010 Feb; 17(2):116-25. PubMed ID: 19577454
[TBL] [Abstract][Full Text] [Related]
20. Impact of lenalidomide on the functional properties of human mesenchymal stromal cells.
Wobus M; Benath G; Ferrer RA; Wehner R; Schmitz M; Hofbauer LC; Rauner M; Ehninger G; Bornhäuser M; Platzbecker U
Exp Hematol; 2012 Oct; 40(10):867-76. PubMed ID: 22705469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
